AHG vs COR
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
AHG · Akso Health$1.35 ▲ 4.25%
COR · Cencora$333.56 ▼ 1.80%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- AHG -14.0%
- COR -7.8%
Head to head
| Metric | AHG | COR |
|---|---|---|
| Price | $1.35 | $333.56 |
| Change today | ▲ 4.25% | ▼ 1.80% |
| Market cap | $1.16B | $63.65B |
| Return, 3 months | 0.0% | +2.8% |
| Return, year to date | -17.7% | -0.7% |
| Return, 1 year | -14.0% | -6.8% |
| P/E (TTM) | – | 18.6 |
| P/B | 6.4 | 17.3 |
| P/E percentile vs own 5y | 2nd | 56th |
| Dividend yield | – | 0.72% |
| Revenue growth (YoY, latest qtr) | +25.5% | +5.1% |
| Net profit growth (YoY) | +40.2% | +12.6% |
| Gross margin | -0.1% | 4.0% |
| Operating margin | -28.9% | 1.4% |
| Net margin | -135.0% | 0.8% |
| Return on equity | -9.8% | 104.3% |
| Analyst target vs. price | – | +13.6% |
| Analyst buy share | – | 82% |
| RSI (14) | 57 | 52 |
| 30-day volatility | 121.3% | 26.9% |
| Max drawdown, 1 year | -72.4% | -32.4% |
| Trend read | Leaning bullish | Leaning bullish |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- COR is the largest of the group by market value.
- COR has returned the most over the past year.
- AHG is growing revenue fastest.
- COR keeps the most profit per dollar of sales.
- COR has been the calmest stock over the last 30 days.